We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Geneva-based World Health Organization (WHO) has published a paper on Merck's human papillomavirus (HPV) vaccine Gardasil, saying that "countries face tough decisions before making the vaccine widely available."
South Africa's largest insurance provider, Discovery Health, has persuaded Pfizer to cut the price of its cholesterol drug Lipitor by almost 5 percent, the Johannesburg, South Africa-based Business Day reports.
The FDA has issued a guidance for industry clarifying whether companies submitting drug applications for fixed-dose combination (FDC) and co-packaged versions of previously approved antiretroviral drugs for treating HIV/AIDS must pay user fees under the Prescription Drug User Fee Act, or whether they qualify for a waiver.
Indian drugmaker Ranbaxy Laboratories announced it has signed a new multiyear R&D agreement with GlaxoSmithKline (GSK) that modifies the terms of their existing alliance to provide Ranbaxy expanded drug-development responsibilities and further financial opportunities.
Even though a trial of an HIV microbicide gel was halted last week due to safety issues, a new trial is under way in Uganda of a different microbicide product.